JP2008515980A5 - - Google Patents

Download PDF

Info

Publication number
JP2008515980A5
JP2008515980A5 JP2007536818A JP2007536818A JP2008515980A5 JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5 JP 2007536818 A JP2007536818 A JP 2007536818A JP 2007536818 A JP2007536818 A JP 2007536818A JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5
Authority
JP
Japan
Prior art keywords
osamu
prostaglandins
prevention
ester
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007536818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008515980A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/036558 external-priority patent/WO2006044405A1/en
Publication of JP2008515980A publication Critical patent/JP2008515980A/ja
Publication of JP2008515980A5 publication Critical patent/JP2008515980A5/ja
Pending legal-status Critical Current

Links

JP2007536818A 2004-10-12 2005-10-11 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物 Pending JP2008515980A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61820204P 2004-10-12 2004-10-12
PCT/US2005/036558 WO2006044405A1 (en) 2004-10-12 2005-10-11 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease

Publications (2)

Publication Number Publication Date
JP2008515980A JP2008515980A (ja) 2008-05-15
JP2008515980A5 true JP2008515980A5 (cg-RX-API-DMAC10.html) 2008-11-27

Family

ID=35677621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007536818A Pending JP2008515980A (ja) 2004-10-12 2005-10-11 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物

Country Status (16)

Country Link
US (2) US20060142348A1 (cg-RX-API-DMAC10.html)
EP (1) EP1812426B1 (cg-RX-API-DMAC10.html)
JP (1) JP2008515980A (cg-RX-API-DMAC10.html)
KR (1) KR20070085340A (cg-RX-API-DMAC10.html)
CN (1) CN101076529A (cg-RX-API-DMAC10.html)
AT (1) ATE512144T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005295902A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0517417A (cg-RX-API-DMAC10.html)
CA (1) CA2583710A1 (cg-RX-API-DMAC10.html)
IL (1) IL182489A0 (cg-RX-API-DMAC10.html)
MX (1) MX2007004526A (cg-RX-API-DMAC10.html)
NO (1) NO20072269L (cg-RX-API-DMAC10.html)
NZ (1) NZ554493A (cg-RX-API-DMAC10.html)
RU (1) RU2407736C2 (cg-RX-API-DMAC10.html)
SG (1) SG156637A1 (cg-RX-API-DMAC10.html)
WO (1) WO2006044405A1 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
CA2608116A1 (en) 2005-05-10 2006-11-16 Intermune, Inc. Method of modulating stress-activated protein kinase system
US20090163586A1 (en) 2007-12-20 2009-06-25 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy 205
CA3034994A1 (en) 2008-06-03 2009-12-10 Intermune, Inc. Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders
FR2938538B1 (fr) * 2008-11-17 2011-08-05 Univ Nice Sophia Antipolis Procede de preparation d'acides et d'esters boroniques en presence de magnesium metallique
CA2756870A1 (en) 2009-03-31 2010-10-07 Arqule, Inc. Substituted indolo-pyridinone compounds
JP5841361B2 (ja) * 2011-06-29 2016-01-13 壽製薬株式会社 三環性化合物及びそれを含有する医薬組成物
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
EP3049392B1 (en) * 2013-09-27 2019-02-27 Allergan, Inc. Compounds and methods for skin repair
CA2943363A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
GB201810092D0 (en) 2018-06-20 2018-08-08 Ctxt Pty Ltd Compounds
GB201810581D0 (en) 2018-06-28 2018-08-15 Ctxt Pty Ltd Compounds
RS64931B9 (sr) 2019-06-18 2025-06-30 Pfizer Derivati benzizoxazol sulfonamida

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE195123T1 (de) * 1995-04-03 2000-08-15 Novartis Erfind Verwalt Gmbh Pyrazolderivate und verfahren zu deren herstellung
ZA984040B (en) * 1997-05-15 1998-11-20 Ono Pharmaceutical Co Benzenesulfonamide compounds
IL149103A0 (en) * 1999-11-30 2002-11-10 Pfizer Prod Inc 2,4-diaminopyrimidine compounds useful as immunosuppressants
KR20040022238A (ko) * 2001-08-09 2004-03-11 오노 야꾸힝 고교 가부시키가이샤 카르복실산 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
US20060089353A1 (en) * 2003-03-06 2006-04-27 Maki Iwahashi Indole derivative compounds and drugs containing the compounds as the active ingredient
JP2007516203A (ja) * 2003-07-09 2007-06-21 バイオリポックス エービー 炎症の治療に有用なインドール類
SI1696920T1 (sl) * 2003-12-19 2015-02-27 Plexxikon Inc. Spojine in postopki za razvoj modulatorjev ret

Similar Documents

Publication Publication Date Title
JP2007501251A5 (cg-RX-API-DMAC10.html)
JP2003520232A5 (cg-RX-API-DMAC10.html)
JP2008515980A5 (cg-RX-API-DMAC10.html)
JP2003503454A5 (cg-RX-API-DMAC10.html)
JP2007523049A5 (cg-RX-API-DMAC10.html)
JP2008513467A5 (cg-RX-API-DMAC10.html)
JP2012502037A5 (cg-RX-API-DMAC10.html)
JP2006517944A5 (cg-RX-API-DMAC10.html)
JP2009545527A5 (cg-RX-API-DMAC10.html)
JP2010528011A5 (cg-RX-API-DMAC10.html)
JP2009538898A5 (cg-RX-API-DMAC10.html)
ME02688B (me) Hinazolinoni kao inhibitori humane fosfatidilinozitol 3 - kinaze delta
JP2006503588A5 (cg-RX-API-DMAC10.html)
JP2009537554A5 (cg-RX-API-DMAC10.html)
BRPI0618211B8 (pt) composição farmacêutica contendo pregabalina para dosagem uma vez ao dia e uso do referido composto
JP2005518413A5 (cg-RX-API-DMAC10.html)
JP2008505857A5 (cg-RX-API-DMAC10.html)
JP2008513510A5 (cg-RX-API-DMAC10.html)
JP2007536277A5 (cg-RX-API-DMAC10.html)
JP2007523135A5 (cg-RX-API-DMAC10.html)
DE602008006243D1 (de) Pharmazeutische kombination aus aliskiren und valsartan
JP2003526626A5 (cg-RX-API-DMAC10.html)
JP2006506499A5 (cg-RX-API-DMAC10.html)
JP2019151627A5 (cg-RX-API-DMAC10.html)
JP2008513426A5 (cg-RX-API-DMAC10.html)